A coalition of major international NGOs is refusing to comply with Israeli orders to hand over detailed staff information, calling it a safety risk and an obstruction of aid, as tensions escalate following the expulsion of Médecins Sans Frontières.
While recent performance has moderated, Mercantile Bank Corporation (NASDAQ:MBWM) has rewarded long-term investors with a total shareholder return more than double the broader market's gains over the past half-decade, driven by consistent earnings growth and dividends.
Amidst a cautiously optimistic economic backdrop in the Eurozone, we spotlight three lesser-known companies with strong fundamentals that investors may be overlooking. From medical supplies to IT services, these firms demonstrate resilience and potential for the year ahead.
Amid a cautiously recovering Eurozone economy, dividend-paying stocks are gaining attention from investors seeking reliable income and a buffer against market volatility. We analyze three standout European companies offering compelling yield and value.
CECO Environmental Corp. (NASDAQ: CECO) has surged in recent months, nearing its yearly high. With the mid-cap clean tech firm now trading near fair value, we analyze whether investors have missed the bargain window or if strategic entry points remain.
LGI Homes deepens its California footprint with a new solar-equipped community near Modesto, bundling high-value upgrades to attract buyers. While the move underscores a strategic shift towards energy efficiency, analysts question its immediate impact on the homebuilder's strained margins and growth trajectory.
Pharmaceutical giant Eli Lilly announces a massive $3.5 billion investment in a new Pennsylvania manufacturing facility dedicated to next-generation weight-loss drugs, signaling a long-term strategic commitment to the obesity market amid intense competition.
Merck & Co. shares have delivered impressive multi-year returns, climbing over 80% in the past five years. Yet, a deep dive into its valuation metrics suggests the market may still be underestimating the pharmaceutical leader's intrinsic value, presenting a potential opportunity for investors.
U.S. stock futures retreated Monday as investors parsed a mixed bag of global manufacturing data, raising fresh questions about the durability of corporate earnings against a backdrop of cooling factory activity in key European economies.
A recent adjustment to Dexterra Group's price target by analysts, issued without detailed rationale, has stirred debate among market watchers. The move prompts a closer look at the underlying factors that may be influencing valuation models for the facilities management and workforce accommodation provider.
The vital Rafah border crossing between Gaza and Egypt partially reopened Monday, allowing severely limited civilian movement for the first time since its capture by Israeli forces in 2024. The cautious resumption follows intense international pressure but falls far short of addressing Gaza's overwhelming humanitarian crisis.
French IT giant Capgemini initiates the sale of its U.S. federal subsidiary, Capgemini Government Solutions, attributing the move to restrictive oversight rules for classified contracts and a desire for strategic focus.
The global professional services firm Aon posted a net income of $1.7 billion for the final quarter of 2025, fueled by robust growth in its commercial risk and reinsurance divisions, while full-year revenue climbed 9% to $17.2 billion.
While analyst price targets often paint a rosy picture, a closer look reveals a more nuanced reality. We examine one favored stock with solid fundamentals and two others where the Street's optimism may be overlooking critical risks.
As several prominent stocks test 52-week lows, investors face a critical choice: identify oversold opportunities or steer clear of troubled names. We analyze one company showing signs of a turnaround and two where caution may be warranted.
While growth often requires investment, a sustained negative free cash flow can signal deep-seated issues. We examine three well-known companies where the cash burn warrants a cautious approach from investors.
Mazda Motor Corporation's global vehicle production saw a significant rebound in December 2025, offering a positive end to a year where overall output and sales declined. The recovery was driven by strong domestic performance and a mixed picture overseas.
While small-cap stocks have broadly underperformed, recent insider buying activity points to potential value in select global companies. We examine three firms where leadership is putting their own capital to work.
Despite a 6.8% stock decline over six months, lagging the S&P 500, Robinhood's robust user monetization, path to profitability, and strong cash flow present a compelling case for long-term believers.
While OceanFirst Financial (OCFC) has kept pace with the market, analysts highlight concerns over its weak net interest income growth, modest earnings expansion, and a projected decline in tangible book value. The search for value shifts focus elsewhere.
